Skip to content
Open access

NEAT1 remodeling rewires the MYC degradation pathway

Oct 2026 · Nucleic Acids Research · Vol 54 · 0 citations · 57 references
Medicine

TL;DR

It is demonstrated that the functional output of a scaffold lncRNA is encoded in its sub-domain architecture rather than bulk transcript levels, establishing domain-specific RNA targeting as a tractable strategy to rewire protein turnover pathways for otherwise undruggable oncogenes.

Abstract

Abstract MYC is among the most frequently amplified oncogenes in human cancer, yet its intrinsically disordered nature has rendered it refractory to direct pharmacological targeting. Here, we demonstrate that the long noncoding RNA NEAT1_1 functions as a molecular gatekeeper that controls MYC protein stability by regulating its access to the E3 ubiquitin ligase UBR5. We show that NEAT1_1 forms a ribonucleoprotein (RNP) complex with both MYC and UBR5, and that NEAT1_1 suppression disrupts this interaction, leading to decreased MYC polyubiquitination and enhanced protein stability. To systematically map the regulatory architecture of NEAT1_1 without altering its abundance, we screened 88 antisense oligonucleotide (ASO) mixmers tiling across the transcript. Strikingly, this phenotypic screen identified region-specific mixmers that elicit bidirectional control over MYC, either driving robust MYC destabilization or promoting its stabilization in a strictly expression-independent manner. Mechanistically, MYC-destabilizing mixmers selectively enhance the interaction between MYC and UBR5 to accelerate proteasomal degradation. A focused CRISPR screen targeting the ubiquitin–proteasome pathway independently validated UBR5 as the essential E3 ligase mediating this mixmer-induced turnover. In vivo, our lead mixmer ASO_#24 significantly suppressed tumor growth in MYC-high xenografts, whereas MYC-low tumors remained unaffected. Our findings reveal that the functional output of a scaffold lncRNA is encoded in its sub-domain architecture rather than bulk transcript levels, establishing domain-specific RNA targeting as a tractable strategy to rewire protein turnover pathways for otherwise undruggable oncogenes.

Read PDF

Similar papers

Sep 2026

A HUWE1 regulatory helix gates ASCL1 degradation through its C-terminal phospho-degron in small cell lung cancer.

Combined genome-wide CRISPR knockout screening with base editor tiling screens at amino acid resolution reveal molecular rules governing HUWE1 phospho-degron recognition and identify a regulatory gate controlling substrate engagement and illustrate a generalizable strategy for resolving degradation mechanisms of undrug...

Keita Masuzawa, Kevin D. Dong, Calvin XiaoYang Hu et al. · 0 citations
Review Open access Sep 2026

Hypertranscription: the invisible hand in cancer epigenetics

Global upregulation of transcription, or hypertranscription, is observed in most human cancers, driven by the action of oncogene-encoded transcription factors (TFs). TF interactions with RNA Polymerase II (Pol II) are mediated by kinases that phosphorylate the Pol II C-terminal domain (CTD) to drive productive elongati...

S. Henikoff, Robert N. Eisenman, K. Ahmad · 0 citations
Open access Oct 2026

MYC targeted de novo binders impair tumor growth

A panel of de novo designed intracellular protein binders that target conserved functional regions of MYC with nanomolar affinity, remodel MYC complexes and interaction networks in cells, suppress proliferation across MYC-dependent cancer models, and are depleted from orthotopic pancreatic tumors in vivo are developed.

N. McNamara-Bordewick, Ke-Jia Wu, Yu-Long Su et al. · 0 citations
Open access Oct 2026

Chemogenetic ubiquitin E1 inhibitor TAK-243 CRISPR screen uncovers HAPSTR1/HUWE1 axis in chromatin proteostasis and cell cycle control

These findings uncover protein networks exhibiting synthetic lethality with ubiquitin signaling blockade and highlight vulnerabilities of actively proliferating cells to proteostatic imbalance at the chromatin.

N. V. van Overbeek, L. Clijsters, M. Wirth et al. · 0 citations
#gene editing Review Open access Oct 2026

Beyond Paraspeckles: Rethinking NEAT1 as Master Regulator of Genome Organization

Evidence reframes NEAT1 as an adaptor molecule in transcriptional machinery whose function is deeply influenced by cellular stimuli, interacting partners and chromatin targets accessible in each context, which raises new mechanistic questions and underscores the challenges of therapeutically targeting NEAT1.

N. Puccio, Federica Torricelli, N. Amodio et al. · 0 citations
Review Open access Sep 2026

PABPC1 in Cancer: From a Translational Housekeeper to a Stress‐Responsive Regulatory Hub

This review synthesizes recent paradigm shifts that redefine PABPC1 function: From global translation maintenance to selective oncogenic mRNA amplification via liquid–liquid phase separation; from binary protein‐RNA interactions to complex regulatory networks involving lncRNAs and circRNAs that modulate PABPC1 stabilit...

Cui-Wei Zhang, Ye Zhu, Wen-Bo Long · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.